RecruitingEarly Phase 1NCT06684639

A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma

Studying Neuroblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The General Hospital of Western Theater Command
Principal Investigator
Hai Yi, Ph.D
The General Hospital of Western Theater Command
Intervention
GD2-CAR-T cell(biological)
Enrollment
30 enrolled
Eligibility
1-18 years · All sexes
Timeline
2024 – 2030

Study locations (1)

Collaborators

Yake Biotechnology Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06684639 on ClinicalTrials.gov

Other trials for Neuroblastoma

Additional recruiting or active studies for the same condition.

See all trials for Neuroblastoma →

← Back to all trials